@hubermanlab post

Audited July 11, 2026

Supported

Claim 1 (GLP-1 RAs / Retinoids) is strongly supported by human RCT evidence, including active Phase 3 trials. Claim 2 (Melanotan and GH secretagogues with RCT support) finds no clinical trial evidence and should be rated no_evidence. Claim 3 (BPC-157 for post-exercise injury) is supported by consistent preclinical data (animal models) and aligns with documented healing mechanisms, though human trials are lacking. Overall, the peptide claims range from well-supported (GLP-1) to preclinically sound but clinically unvalidated (BPC-157) to unsupported by trial data (Melanotan/GH secretagogues).

Share this audit

One link — full verdict, every claim, and PubMed citations included.

peptiq.io/check/6ddc6283

Shareable link includes the full verdict, claims, and PubMed citations.

Post captionshow

PEPTIDE SOURCES & SAFETY • - My guest on the Huberman Lab podcast out now is Dr Abud Bakri, MD @abud_bakri We discuss peptides: BPC, GLPs (incl Retatrutide), GHK-Cu, Pinealon, Epitalon, TB500 and Thymosin, and more. The topic of sourcing came up and broadly speaking there are four categories: 1) Pharma (brand name): highest stringency, with respect to purity. 2) Compounding Pharmacies: here

Show full post caption

, there’s a huge range of quality, purity, and cost. There are some excellent compounding pharmacies out there. We discussed the more reputable ones on the podcast. This source still requires a prescription. 3) Gray Market: compounds being sold without prescription labeled “for research purposes only, not for animal or human use”. The range of quality and purity is vast. 4) Black market: not *necessarily* “home grown” but zero validation about what you’re taking. In theory, this is also a problem with certain gray market sources, but even more extreme with black market sources. The episode gets into the fact that for some peptides— in particular the GLPs/Reta there are randomized controlled trials to support their specific uses, (also true for Melanotan and GH secretagouges) but many people are taking these compounds for things other than what they were studied and approved for. (Off label use of FDA compounds is not on unusual but typically it’s a doctor making those decisions not the patient). For anyone who is peptide curious, skeptical, or anti-peptides (that are not studied with randomized control trials) as well as people who are very pro peptides will benefit from listening to the episode. You can find it at hubermanlab.com & on all podcast platforms. Thank you for your interest in science! @stanford @stanford.med

Show less
Video transcriptshow

The quote unquote gray market peptides, the ones where it's quote unquote for research purposes only, but I made the joke on X a few weeks ago. Like how many of you are running experiments and you're not on animals? What are you doing? Cell culture at home? Like, come on. I know what's involved in doing cell culture. You're not doing this at home. So those presumably also come in anywhere from exc

Show full video transcript

ellent to dreadful. Yes. But we don't know which are which. Nope. We don't know that. And batch to batch. That's the big problem. Okay. So it is risky to get for research purposes. Yeah, yeah. I mean, that's the majority of the way people are consuming peptides. Unfortunately, we should just, because of the move in 2024 to get these from the category one to the category two list and make them banned, quote unquote, that opened up this gray market zone. Like the gray market existed for the last 15, 20 years. Bodybuilders would, you know, have anecdotes about BPC-157. They'd inject it post, you know, post squats for different injuries. Nobody really cared about it. It was with the GLP-1s and then the banning of the peptides, plus this, you know, anti-medicine kick that's been happening over the last five years. Since the pandemic. Yes, since the pandemic. That people are like you know what I want to inject this because it gives them a sense of autonomy or they feel like their bro recommended it like I said the best job in 2025 was to be a peptide affiliate people made my yearly salary in a month selling peptides illegally on TikTok

Show less

Claim breakdown

3 claims
1

for some peptides— in particular the GLPs/Reta there are randomized controlled trials to support their specific uses

Supported

GLP-1 receptor agonists (semaglutide, tirzepatide) have robust human RCT evidence for metabolic and weight management outcomes. NCT07165028 (Phase 3, active) is testing tirzepatide in metabolic dysfunction-associated steatotic liver disease (MASLD), representing the type of rigorous clinical validation the claim references. Multiple published Phase 2/3 trials in PubMed demonstrate efficacy in glucose control and weight reduction, supporting the claim that GLPs/reta have RCT backing for specific uses.

2

some peptides like Melanotan and GH secretagouges have randomized controlled trials to support their specific uses

No Evidence

No registered human clinical trials were found for Melanotan or GH secretagogues (Ipamorelin, GHRP-2, GHRP-6, Sermorelin) in ClinicalTrials.gov. PubMed search yielded no human RCT evidence supporting specific clinical uses for either compound class. While GH secretagogues have preclinical/animal model data and are used off-label, the claim specifically asserts RCT support—which is absent from the accessible literature.

3

Bodybuilders would have anecdotes about BPC-157 for injuries post squats.

Supported

BPC-157 has consistent preclinical evidence (animal models) supporting tendon and soft-tissue healing mechanisms. The Sikiric et al. (2018) study (PMID: 29713566) demonstrates accelerated tendon repair in animal models. Internal PeptIQ references confirm BPC-157 is extensively researched for tissue healing and tendon recovery. Bodybuilder anecdotes align with the documented mechanistic direction—though human RCT data is not yet available. The claim's conceptual basis (BPC-157 aids injury recovery post-exercise) is supported by preclinical literature.

Audit another post

Instagram, Reddit, or paste text directly.

New audit

Track your protocols

Dosing, logging, and reminders in the app.

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error